GET THE APP

Method development and validation of simultaneous determination of Ofloxacin and Satranidazole in pharmaceutical dosage form by RP-HPLC | Abstract
Scholars Research Library

Scholars Research Library

A-Z Journals

+44 7389645282

Der Pharmacia Lettre

Abstract

Method development and validation of simultaneous determination of Ofloxacin and Satranidazole in pharmaceutical dosage form by RP-HPLC

Author(s): D. Boopathy, M. Prakash , Bibin Mathew, S. Suresh Kumar and P. Perumal

A simple, selective, rapid, and precise reverse phase HPLC method has been developed for the simultaneous estimation of Ofloxacin and Satranidazole in pharmaceutical dosage form. A Phenomenex Luna C18 (4.6*250 mm, 5μ) column was used for the separation. The mobile phase was Phosphate buffer: Acetonitrile (70: 30 % v/v) and pH 6.0 at a flow rate of 1.2ml/min with detection at 300nm.The retention time of Ofloxacin and Satranidazole was 3.720and 6.130min, respectively. The developed method was validated in term of accuracy, precision, specificity, system suitability, linearity, and robustness, limit of detection and limit of quantification. The proposed method is suitable for simultaneous determination of Ofloxacin and Satranidazole in pharmaceutical dosage form.